Ignite Creation Date:
2024-05-06 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05213143
Status:
TERMINATED
Last Update Posted:
2024-04-19
First Post:
2021-12-05
Brief Title:
The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine
Sponsor:
Sumitomo Pharma Suzhou Co Ltd
Organization:
Sumitomo Pharma Suzhou Co Ltd
Organization Data
Organization:
Sumitomo Pharma Suzhou Co Ltd
Class:
INDUSTRY
Study ID:
DSPC-LAT-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sumitomo Pharma Suzhou Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None